Correlation Between Enzo Biochem and Exagen
Can any of the company-specific risk be diversified away by investing in both Enzo Biochem and Exagen at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Enzo Biochem and Exagen into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Enzo Biochem and Exagen Inc, you can compare the effects of market volatilities on Enzo Biochem and Exagen and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Enzo Biochem with a short position of Exagen. Check out your portfolio center. Please also check ongoing floating volatility patterns of Enzo Biochem and Exagen.
Diversification Opportunities for Enzo Biochem and Exagen
-0.56 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Enzo and Exagen is -0.56. Overlapping area represents the amount of risk that can be diversified away by holding Enzo Biochem and Exagen Inc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Exagen Inc and Enzo Biochem is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Enzo Biochem are associated (or correlated) with Exagen. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Exagen Inc has no effect on the direction of Enzo Biochem i.e., Enzo Biochem and Exagen go up and down completely randomly.
Pair Corralation between Enzo Biochem and Exagen
Considering the 90-day investment horizon Enzo Biochem is expected to under-perform the Exagen. In addition to that, Enzo Biochem is 1.12 times more volatile than Exagen Inc. It trades about 0.0 of its total potential returns per unit of risk. Exagen Inc is currently generating about 0.05 per unit of volatility. If you would invest 230.00 in Exagen Inc on August 28, 2024 and sell it today you would earn a total of 175.00 from holding Exagen Inc or generate 76.09% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Very Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Enzo Biochem vs. Exagen Inc
Performance |
Timeline |
Enzo Biochem |
Exagen Inc |
Enzo Biochem and Exagen Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Enzo Biochem and Exagen
The main advantage of trading using opposite Enzo Biochem and Exagen positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Enzo Biochem position performs unexpectedly, Exagen can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Exagen will offset losses from the drop in Exagen's long position.Enzo Biochem vs. Fonar | Enzo Biochem vs. Burning Rock Biotech | Enzo Biochem vs. Sera Prognostics | Enzo Biochem vs. Psychemedics |
Exagen vs. Fonar | Exagen vs. Burning Rock Biotech | Exagen vs. Sera Prognostics | Exagen vs. Castle Biosciences |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.
Other Complementary Tools
Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years |